RankingsPricing
  1. JP-listed companies
  2. KYORIN Pharmaceutical Co., Ltd.
  3. Financials
  4. Total liabilities

KYORIN Pharmaceutical Co., Ltd.【JP:4569】

Market cap
¥103.3B
P/E ratio
19.1x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal liabilities (Million JPY)YoY (%)
Mar 31, 202557,333+22.26%
Mar 31, 202446,896-7.29%
Mar 31, 202350,584+6.68%
Mar 31, 202247,416+11.66%
Mar 31, 202142,464-12.35%
Mar 31, 202048,449-2.40%
Mar 31, 201949,639+41.61%
Mar 31, 201835,053+0.64%
Mar 31, 201734,831-14.58%
Mar 31, 201640,776+17.23%
Mar 31, 201534,782

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)